Dr. Anath Flugelman is involved in several screening activities, including the Israeli colorectal and breast cancer screening programs. She was the public health physician in charge of FIT implementation in Israel in 2016, and the physician in charge of mammographic program quality assurance. Her research includes time between FOBT and colonoscopy associated with mortality, mammographic cumulative density and breast cancer incidence in age/ethnic groups, family history in screening, post colonoscopy colorectal cancer screening within screening programs. Dr. Flugelman participates in several cancer screening networks, including the International Consortium on Mammographic Density and the World Endoscopy Organization.